MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ProKidney (PROK) Ownership - Who owns ProKidney?
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more
Profile
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
86.62M
P/E Ratio
N/A
Total Cash
328.5M
Projected Growth
N/A
Total Debt
3.37M
Revenue
306K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.54
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
PROK
Capitalization
86.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
328M
Total Cash/Share
2.54
Total Debt
3.37M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
306K
ROE
N/A
Book Value
-998.55M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
10.96
Current Revenue Per Employee
1127.45
Dividends Per Share - Security
N/A
EBITDA
-160.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.24
Shares Held By Institutions
112M
Shares Outstanding - Current
130M
Total Liabilities
36.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-60.432
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com